Search research articles
Contact Us
Filters
Showing results (111-120 of 184) with videos related to
Page
of 19
Sort By:
Oncotarget
|
December 22, 2016
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
Florian Selt, Juliane Hohloch, Thomas Hielscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2011
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma
Marc Remke, Thomas Hielscher, Andrey Korshunov, et al.
Acta Neuropathologica
|
August 15, 2014
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells
Mark Barszczyk, Pawel Buczkowicz, Pedro Castelo-Branco, et al.
Neuro-Oncology
|
August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
Jonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Acta Neuropathologica
|
May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Torsten Pietsch, Rene Schmidt, Marc Remke, et al.
Acta Neuropathologica
|
December 14, 2011
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
Andrey Korshunov, Marc Remke, Marcel Kool, et al.
Acta Neuropathologica
|
April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Vijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
American Journal of Human Genetics
|
February 1, 2020
Bi-allelic Variants in RALGAPA1 Cause Profound Neurodevelopmental Disability, Muscular Hypotonia, Infantile Spasms, and Feeding Abnormalities
Matias Wagner, Yuliya Skorobogatko, Ben Pode-Shakked, et al.
Journal of Neuro-Oncology
|
May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
Gintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Hemasphere
|
April 3, 2025
H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia
Vera H Jepsen, Andrea Hanel, Daniel Picard, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 184) with videos related to
Sort By:
Page
of 19
Oncotarget
|
December 22, 2016
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
Florian Selt, Juliane Hohloch, Thomas Hielscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2011
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma
Marc Remke, Thomas Hielscher, Andrey Korshunov, et al.
Acta Neuropathologica
|
August 15, 2014
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells
Mark Barszczyk, Pawel Buczkowicz, Pedro Castelo-Branco, et al.
Neuro-Oncology
|
August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
Jonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Acta Neuropathologica
|
May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Torsten Pietsch, Rene Schmidt, Marc Remke, et al.
Acta Neuropathologica
|
December 14, 2011
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
Andrey Korshunov, Marc Remke, Marcel Kool, et al.
Acta Neuropathologica
|
April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Vijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
American Journal of Human Genetics
|
February 1, 2020
Bi-allelic Variants in RALGAPA1 Cause Profound Neurodevelopmental Disability, Muscular Hypotonia, Infantile Spasms, and Feeding Abnormalities
Matias Wagner, Yuliya Skorobogatko, Ben Pode-Shakked, et al.
Journal of Neuro-Oncology
|
May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells
Gintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Hemasphere
|
April 3, 2025
H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia
Vera H Jepsen, Andrea Hanel, Daniel Picard, et al.
Page
of 19